PriceTargets.com logo

Prenetics Global - PRE Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $9.00
  • Forecasted Upside: 52.54%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$5.90 As of 07/26/2024 01:00 AM ET
▲ +0.04 (0.68%)

This chart shows the closing price for PRE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Prenetics Global Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PRE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PRE

Analyst Price Target is $9.00
▲ +52.54% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Prenetics Global in the last 3 months. The average price target is $9.00, with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 52.54% upside from the last price of $5.90.

This chart shows the closing price for PRE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in Prenetics Global. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/2/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/3/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/28/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/27/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/26/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/4/2024Cantor FitzgeraldLower TargetOverweight ➝ Overweight$10.00 ➝ $9.00Low
9/26/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$60.00Low
9/19/2023Cantor FitzgeraldLower TargetOverweight ➝ Overweight$90.00 ➝ $60.00Low
8/22/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00Low
1/18/2023Cantor FitzgeraldInitiated CoverageOverweight$105.00Low
7/12/2022CitigroupInitiated CoverageBuyLow
(Data available from 7/27/2019 forward)

News Sentiment Rating

0.59 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/30/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/29/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/28/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/29/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
4/28/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/28/2024
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/27/2024
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/27/2024

Current Sentiment

  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Prenetics Global logo
Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.
Read More

Today's Range

Now: $5.90
Low: $5.66
High: $6.06

50 Day Range

MA: $5.95
Low: $5.32
High: $6.80

52 Week Range

Now: $5.90
Low: $2.85
High: $12.35

Volume

29,789 shs

Average Volume

72,282 shs

Market Capitalization

$53.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Prenetics Global?

The following Wall Street sell-side analysts have issued research reports on Prenetics Global in the last year: Cantor Fitzgerald.
View the latest analyst ratings for PRE.

What is the current price target for Prenetics Global?

1 Wall Street analysts have set twelve-month price targets for Prenetics Global in the last year. Their average twelve-month price target is $9.00, suggesting a possible upside of 52.5%. Cantor Fitzgerald has the highest price target set, predicting PRE will reach $9.00 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $9.00 for Prenetics Global in the next year.
View the latest price targets for PRE.

What is the current consensus analyst rating for Prenetics Global?

Prenetics Global currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PRE will outperform the market and that investors should add to their positions of Prenetics Global.
View the latest ratings for PRE.

What other companies compete with Prenetics Global?

Other companies that are similar to Prenetics Global include Harvard Bioscience, Seer, Akoya Biosciences, Bionano Genomics and Accelerate Diagnostics. Learn More about companies similar to Prenetics Global.

How do I contact Prenetics Global's investor relations team?

Prenetics Global's physical mailing address is 71 Fort Street PO Box 500, Grand Cayman E9, KY1-1106. The company's listed phone number is 852-2210-9588. The official website for Prenetics Global is www.prenetics.com. Learn More about contacing Prenetics Global investor relations.